美国 FDA批准使用新型冠状病毒康复者的血浆作为治疗方法, 新西兰将延长当地三 级封锁措施多一星期

In 每日市场分析
August 25, 2020

美国 FDA批准使用新型冠状病毒康复者的血浆作为治疗方法
美国食品及药物管理局(FDA)周日(23 日)宣布,批准使用新型冠状病毒康复者的血浆,作为治疗该病的方法,并发出紧急使用许可。 FDA 於声明中表示,血浆疗法可能有效治疗新冠病毒,其已知和潜在的好处大於风险,并指出已有超过 7 万名新冠病毒患者用过血浆疗法。不过,此疗法的有效程度仍受部份国外专家所质疑,甚至警告血浆疗法可能会产生副作用「血清病」,严重者或会导致器官衰竭。

新西兰将延长当地三级封锁措施多一星期
新西兰总理阿德恩周一 (24 日) 宣布,将延长当地三级封锁措施有效期最少一个星期,包括强制民众在公共交通工具戴口罩。受疫情封锁措施影响,新西兰本年第二季零售销按年大跌 14.2%,结束连季上升走势,是 25 年来最大跌幅。市场估计,於封锁限制下,每周将造成约 4.4 亿新西兰元的经济损失,相等於年 GDP 的 0.15%。若封锁措施短期内未能解除,势将对当地经济造成重大冲击。

————————————
Z. com Bullion为日本上市集团GMO Financial Holdings, Inc 旗下关联公司。杠杆式保证金交易存在高风险 , 有关风险请浏览公司网站https://bullion.z.com/tc/about/legal/risk/

場外式黃金/白銀交易的風險:
Service relating to Over-the-counter (OTC) Gold Bullion/Silver trading is provided by MOL. OTC Gold/Silver Bullion trading carries a high degree of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. OTC Gold/Silver Bullion is not regulated by the Securities and Futures Commission (""SFC"") and therefore trading OTC Gold/Silver Bullion will not be subject to rules or regulations promulgated by the SFC. Before deciding to trade OTC Gold/Silver Bullion you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain losses in excess of your deposited fund or even more in extreme circumstances and therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading OTC Gold/Silver Bullion, and seek advice from an independent financial advisor if you require.